HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Pranoprofen

HCID 4888
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
52549-17-4
Standard SMILES
CC(C(=O)O)c1ccc2c(c1)Cc1cccnc1O2
InChIKey
TVQZAMVBTVNYLA-UHFFFAOYSA-N
Molecular formula
C15H13NO3
Average molar mass
255.27 g/mol
Monoisotopic mass
255.08954328

Overview

Pranoprofen is a pyridochromene.

Names & identifiers

Preferred name
Pranoprofen
IUPAC
2-(5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid
English name
Pranoprofen
Molecular formula
C15H13NO3
Molecular weight
255.27

Names & synonyms

pranoprofen52549-17-4pyranoprofenPranoprofenoPranoprofenePranoprofenumElicapricDTXSID1023497NSC-7598322R7O1ET613DTXCID603497alpha-Methyl-5H-(1)benzopyrano(2,3-b)pyridine-7-acetic acid
Show more names
Y 8004CesflanOftalarPralofenPraprofenranoprofen
(2RS)-2-(10H-9-Oxa-1-azaanthracen-6-yl)propanoic acid(+-)-PranoprofenRefChem:868380S01BC09Niflan2-(5H-chromeno[2,3-b]pyridin-7-yl)propanoic acidY-80042-(5H-[1]-Benzopyrano[2,3-b]pyridin-7-yl)propionic Acid

Database identifiers

CAS
52549-17-4
PubChem CID
4888
DTXSID
DTXSID1023497
ChEMBL
CHEMBL367463
ChEBI
CHEBI:32040
UNII
2R7O1ET613
EC Number
682-035-7
Nikkaji
J9.293B

Properties

Computed structural properties

XLogP
2.7
Topological polar surface area
59.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
4
Rotatable bonds
2
Heavy atoms
19
Formal charge
0
Complexity
346

Experimental & physicochemical properties

Endocrine DisruptorsPotential endocrine disrupting compound

Physicochemical properties

Melting point
182 · 182-183°
Boiling point
398.5 °C · 398.5°C (rough estimate)
Density
1.1654 · 1.1654 (rough estimate)
refractive index
1.55 · 1.5500 (estimate)
storage temp.
2 · 2-8°C
solubility
DMSO (Slightly), Methanol (Slightly)
pka
4.27 · 4.27±0.10(Predicted)
form
powder
color
white to beige
InChI
InChI=1S/C15H13NO3/c1-9(15(17)18)10-4-5-13-12(7-10)8-11-3-2-6-16-14(11)19-13/h2-7,9H,8H2,1H3,(H,17,18)
InChIKey
TVQZAMVBTVNYLA-UHFFFAOYSA-N
SMILES
C(C1C=CC2OC3=NC=CC=C3CC=2C=1)(C)C(=O)O

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P264+P265, P270, P280, P301+P316, P302+P352, P305+P351+P338, P321, P330, P332+P317, P337+P317, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 3 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 3 (100%)

Toxicology

Drug Induced Liver Injury · 4 items

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Pranoprofen

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Safety data

wgk
WGK 1
rtecs
DJ3100950
ridadr
UN 2811 6.1 / PGIII
Toxicity
LD50 in male mice, rats (mg/kg): 447.3, 87.3 orally (Edanaga)
Signal word
Danger
Symbol(GHS)
GHS06
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard statements
H301
Hazard Classifications

Chemistry & industry

Pharmacology

ATC Code · 3 items

S01BC09

S - Sensory organs

QS - Sensory organs

Mechanism of ActionPranoprofen is a cyclo-oxygenase inhibitor.
MeSH Pharmacological Classification · 2 items

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Agents that increase uric acid excretion by the kidney (URICOSURIC AGENTS), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout.

Cellular LocationsMembrane

Applications

UsesPranoprofen is an anti-inflammatory used in ophthalmology.

General DescriptionPranoprofen is an arylalkanoic acid and a non-steroidal anti-inflammatory drug.

Preparation methods · 1 item

PreparationUsing 2-chloronicotinic acid as a raw material, it is condensed with phenol under a strongly alkaline environment, then dehydrated by polyphosphoric acid, reduced by potassium borohydride, then hydrolyzed in acid, and finally acylated with chloroacetyl chloride. After hydrolysis under alkaline conditions, it is acylated by sulfonyl chloride and finally rearranged to obtain pranoprofen.

Upstream & downstream products

Related reactions

8 records
New reaction record
HRID 85793 reaction equation
HRID 85793As product
HRID 1148970 reaction equation
HRID 1148970As product
HRID 1579448 reaction equation
HRID 1579448As product
HRID 1579450 reaction equation
HRID 1579450As product
HRID 1579451 reaction equation
HRID 1579451As product
HRID 1579452 reaction equation
HRID 1579452As product
HRID 1579455 reaction equation
HRID 1579455As reactant
HRID 1579456 reaction equation
HRID 1579456As reactant

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CAS DataBase Reference
52549 · 52549-17-4(CAS DataBase Reference)
FDA UNII
2 R7O1ET613 · 2R7O1ET613
ATC code
1 BC09 · S01BC09
Comptox DTXSID
1023497 · DTXSID1023497
UNSPSC Code
41106500 · 41106500
NACRES
77 · NA.77
Symbol(GHS)
6 · GHS06
Signal word
Danger
Hazard statements
301 · H301
Precautionary statements
301 · P301+P310+P330
RIDADR
2811 · UN 2811 6.1 / PGIII
WGK Germany
1 · WGK 1
RTECS
3100950 · DJ3100950
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 Oral · Acute Tox. 3 Oral
Toxicity
50 in · LD50 in male mice, rats (mg/kg): 447.3, 87.3 orally (Edanaga)
Acute Tox. 3 Oral
Precautionary statements
P301+P310+P330

Upstream raw materials

Hydrochloric acid

Additional notes

DefinitionChEBI: Pranoprofen is a pyridochromene.